65
DaBomb Protein Biotech Corp.
6578.TWO · TWO
$16.80 +0.60% (+$0.10)
1M -8.13%
Market Cap $1.20B
P/E Ratio -
Div. Yield -
ROE 4.17%
Bulios Fair Price
$15.69
6.6% downside
Current Price
$16.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6578.TWO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
26 /100
Expensive P/FCF 47.41x
P/B 1.19x
EV/EBITDA 31.64x
Growth
22 /100
Declining Book val. growth 10.80%
Rev. growth 10.65%
FCF growth N/A
Profitability
21 /100
Weak FCF margin 7.46%
Op. margin 6.34%
Gross margin 16.52%
Quality
0 /100
Poor Asset turnover 0.30x
ROA 3.74%
ROIC 2.44%
Debt
80 /100
Low Net debt/EBITDA -2.00x
Int. coverage -1.93x
Debt/Equity 0.07x
Stability
52 /100
Moderate Profitable years 0
EPS volatility 422.75%
Beta 0.35x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6578.TWO
Online
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Yu Fen Liu
Employees
46
Headquarters
Tainan